TEBENTAFUSP

TEBENTAFUSP was reported 602 times

These side effects are most commonly reported by patients taking TEBENTAFUSP:

# Side effect Count
0 CYTOKINE RELEASE SYNDROME 118
1 PYREXIA 107
2 DISEASE PROGRESSION 73
3 HYPOTENSION 70
4 RASH 69
5 MALIGNANT NEOPLASM PROGRESSION 61
6 CHILLS 59
7 PRODUCT DOSE OMISSION ISSUE 56
8 PRURITUS 44
9 NAUSEA 40
10 VOMITING 36
11 DEATH 32
12 FATIGUE 24
13 HYPOXIA 22
14 DIARRHOEA 20
15 TACHYCARDIA 20
16 ASTHENIA 18
17 OFF LABEL USE 18
18 HEADACHE 15
19 NEOPLASM PROGRESSION 15
20 OXYGEN SATURATION DECREASED 15
21 PAIN 15
22 BLOOD PRESSURE DECREASED 14
23 DYSPNOEA 14
24 ERYTHEMA 14
25 NEUROPATHY PERIPHERAL 13
26 CONFUSIONAL STATE 12
27 HYPERTENSION 12
28 METASTASES TO LIVER 11
29 TACHYPNOEA 11
30 DRUG INEFFECTIVE 10
31 GENERAL PHYSICAL HEALTH DETERIORATION 10
32 MALAISE 10
33 BODY TEMPERATURE INCREASED 9
34 HEPATIC ENZYME INCREASED 9
35 TREMOR 9
36 HEART RATE INCREASED 8
37 HEPATIC LESION 8
38 METASTASIS 8
39 TREATMENT DELAYED 8
40 ABDOMINAL PAIN 7
41 ALANINE AMINOTRANSFERASE INCREASED 7
42 BACK PAIN 7
43 COVID-19 7
44 EYE PAIN 7
45 HAIR COLOUR CHANGES 7
46 HYPERHIDROSIS 7
47 PAIN IN EXTREMITY 7
48 PERIPHERAL SWELLING 7
49 SWELLING FACE 7
50 ASPARTATE AMINOTRANSFERASE INCREASED 6
51 BLOOD PRESSURE ABNORMAL 6
52 DECREASED APPETITE 6
53 DIZZINESS 6
54 HEPATITIS 6
55 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6
56 LACTIC ACIDOSIS 6
57 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
58 RASH MACULO-PAPULAR 6
59 SWELLING 6
60 THERAPY CESSATION 6
61 THERAPY INTERRUPTED 6
62 ACUTE KIDNEY INJURY 5
63 ADVERSE DRUG REACTION 5
64 ATRIAL FIBRILLATION 5
65 BLISTER 5
66 BLOOD BILIRUBIN INCREASED 5
67 BLOOD LACTIC ACID INCREASED 5
68 C-REACTIVE PROTEIN INCREASED 5
69 DEHYDRATION 5
70 GAIT DISTURBANCE 5
71 JAUNDICE 5
72 METASTASES TO BONE 5
73 METASTASES TO CENTRAL NERVOUS SYSTEM 5
74 MYALGIA 5
75 PLATELET COUNT DECREASED 5
76 RASH ERYTHEMATOUS 5
77 RASH PRURITIC 5
78 SEPSIS 5
79 SKIN EXFOLIATION 5
80 SKIN HYPOPIGMENTATION 5
81 UVEAL MELANOMA 5
82 ACUTE MYELOID LEUKAEMIA 4
83 ARTHRALGIA 4
84 BLOOD ALKALINE PHOSPHATASE INCREASED 4
85 BLOOD PRESSURE INCREASED 4
86 CARDIAC ARREST 4
87 DYSGEUSIA 4
88 EYELASH DISCOLOURATION 4
89 FEELING ABNORMAL 4
90 FLUSHING 4
91 GLUCOCORTICOID DEFICIENCY 4
92 HEART RATE DECREASED 4
93 HEPATIC FUNCTION ABNORMAL 4
94 HOSPITALISATION 4
95 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4
96 INFUSION RELATED REACTION 4
97 MENTAL STATUS CHANGES 4
98 OEDEMA PERIPHERAL 4
99 PANCREATITIS 4
100 RENAL FAILURE 4
101 SOMNOLENCE 4
102 TUMOUR LYSIS SYNDROME 4
103 WEIGHT DECREASED 4
104 ABDOMINAL PAIN UPPER 3
105 ANGIOEDEMA 3
106 ASCITES 3
107 BLOOD CREATININE INCREASED 3
108 BLOOD LACTATE DEHYDROGENASE INCREASED 3
109 BONE PAIN 3
110 BRAIN FOG 3
111 COUGH 3
112 DISORIENTATION 3
113 DRUG INTOLERANCE 3
114 ERYTHEMA MULTIFORME 3
115 EXERTIONAL RHABDOMYOLYSIS 3
116 FULL BLOOD COUNT ABNORMAL 3
117 HEPATIC CANCER STAGE IV 3
118 HEPATIC FAILURE 3
119 ILLNESS 3
120 IMMUNE-MEDIATED ADVERSE REACTION 3
121 LIVER FUNCTION TEST INCREASED 3
122 LOSS OF CONSCIOUSNESS 3
123 METABOLIC ACIDOSIS 3
124 METASTASES TO LUNG 3
125 METASTASES TO SKIN 3
126 MUSCULAR WEAKNESS 3
127 MYOSITIS 3
128 PALPITATIONS 3
129 PARAESTHESIA 3
130 PHOTOSENSITIVITY REACTION 3
131 PIGMENTATION DISORDER 3
132 PLEURAL EFFUSION 3
133 PNEUMONIA 3
134 PRODUCT PREPARATION ERROR 3
135 PULMONARY EMBOLISM 3
136 RESPIRATORY FAILURE 3
137 RETCHING 3
138 SEIZURE 3
139 SKIN DISCOLOURATION 3
140 SKIN HYPERPIGMENTATION 3
141 SUBRETINAL FLUID 3
142 THERAPEUTIC RESPONSE DECREASED 3
143 THROMBOCYTOPENIA 3
144 TRANSAMINASES INCREASED 3
145 TUMOUR PAIN 3
146 URINARY RETENTION 3
147 URINARY TRACT INFECTION 3
148 WHITE BLOOD CELL COUNT DECREASED 3
149 ABDOMINAL DISTENSION 2
150 ACUTE RESPIRATORY FAILURE 2
151 ADRENAL INSUFFICIENCY 2
152 ADVERSE EVENT 2
153 AGITATION 2
154 ALOPECIA 2
155 ANAEMIA 2
156 ANAPHYLACTIC REACTION 2
157 ANAPHYLACTIC SHOCK 2
158 ANXIETY 2
159 APHASIA 2
160 ARTHROPOD BITE 2
161 ATELECTASIS 2
162 BALANCE DISORDER 2
163 BRADYCARDIA 2
164 BURNING SENSATION 2
165 CHOROID MELANOMA 2
166 CONSTIPATION 2
167 CONTUSION 2
168 CREATINE KINASE INCREASED 2
169 DEPRESSION 2
170 DISTRIBUTIVE SHOCK 2
171 DRUG INTERACTION 2
172 DYSARTHRIA 2
173 DYSPEPSIA 2
174 DYSPHAGIA 2
175 ELECTROLYTE IMBALANCE 2
176 FALL 2
177 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
178 GASTRITIS 2
179 HAEMOGLOBIN DECREASED 2
180 HEPATIC CANCER 2
181 HEPATIC ENCEPHALOPATHY 2
182 HEPATIC PAIN 2
183 HEPATOMEGALY 2
184 HEPATOTOXICITY 2
185 HYPERTHERMIA 2
186 HYPOALBUMINAEMIA 2
187 HYPOGLYCAEMIA 2
188 HYPONATRAEMIA 2
189 HYPOPHOSPHATAEMIA 2
190 ILL-DEFINED DISORDER 2
191 INFECTION 2
192 INFLUENZA LIKE ILLNESS 2
193 INTENSIVE CARE 2
194 INTRAOCULAR PRESSURE INCREASED 2
195 LEUKOCYTOSIS 2
196 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
197 METASTATIC OCULAR MELANOMA 2
198 MYOCARDITIS 2
199 NECROSIS 2
200 NO ADVERSE EVENT 2
201 OCULAR DISCOMFORT 2
202 OEDEMA 2
203 OROPHARYNGEAL PAIN 2
204 OXYGEN SATURATION ABNORMAL 2
205 OXYGEN THERAPY 2
206 PAIN OF SKIN 2
207 PEMPHIGOID 2
208 PLATELET COUNT ABNORMAL 2
209 PNEUMONITIS 2
210 POLYMYALGIA RHEUMATICA 2
211 PRESCRIBED OVERDOSE 2
212 PROCEDURAL PAIN 2
213 PRODUCT PREPARATION ISSUE 2
214 PRODUCT QUALITY ISSUE 2
215 PRODUCT STORAGE ERROR 2
216 PRODUCT USE ISSUE 2
217 PULSELESS ELECTRICAL ACTIVITY 2
218 RASH VESICULAR 2
219 RENAL DISORDER 2
220 RESPIRATORY DISTRESS 2
221 RETINAL DEGENERATION 2
222 RETINAL DETACHMENT 2
223 SHOCK 2
224 SINUSITIS 2
225 SKIN MASS 2
226 SPEECH DISORDER 2
227 SYNCOPE 2
228 TREATMENT NONCOMPLIANCE 2
229 TUMOUR FLARE 2
230 TUMOUR HAEMORRHAGE 2
231 VITILIGO 2
232 WHITE BLOOD CELL COUNT INCREASED 2
233 ABDOMINAL MASS 1
234 ACCIDENTAL EXPOSURE TO PRODUCT 1
235 ACHROMOTRICHIA ACQUIRED 1
236 ACUTE CORONARY SYNDROME 1
237 ACUTE LYMPHOCYTIC LEUKAEMIA 1
238 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1
239 ACUTE MYOCARDIAL INFARCTION 1
240 ADVERSE REACTION 1
241 ALTERED STATE OF CONSCIOUSNESS 1
242 AMAUROSIS FUGAX 1
243 ANAL PRURITUS 1
244 ANAPHYLACTOID REACTION 1
245 ANTERIOR SEGMENT NEOVASCULARISATION 1
246 ANURIA 1
247 ARTHRITIS 1
248 ASYMPTOMATIC COVID-19 1
249 AUTOIMMUNE DISORDER 1
250 BACK INJURY 1
251 BLINDNESS UNILATERAL 1
252 BLOOD ALBUMIN DECREASED 1
253 BLOOD CALCIUM DECREASED 1
254 BLOOD GLUCOSE DECREASED 1
255 BLOOD GLUCOSE INCREASED 1
256 BLOOD PHOSPHORUS INCREASED 1
257 BLOOD POTASSIUM DECREASED 1
258 BLOOD POTASSIUM INCREASED 1
259 BLOOD PRESSURE FLUCTUATION 1
260 BLOOD PRESSURE SYSTOLIC ABNORMAL 1
261 BLOOD TEST ABNORMAL 1
262 BLOOD URIC ACID INCREASED 1
263 BRADYPNOEA 1
264 BRAIN OEDEMA 1
265 BRAIN STEM HAEMORRHAGE 1
266 BREAST NEOPLASM 1
267 C-REACTIVE PROTEIN ABNORMAL 1
268 CARDIAC DISORDER 1
269 CARDIO-RESPIRATORY ARREST 1
270 CARDIOVASCULAR DISORDER 1
271 CATARACT 1
272 CENTRAL SEROUS CHORIORETINOPATHY 1
273 CEREBROVASCULAR ACCIDENT 1
274 CHAPPED LIPS 1
275 CHEST DISCOMFORT 1
276 CHOLANGITIS 1
277 CHOLELITHIASIS 1
278 CHOROIDAL DYSTROPHY 1
279 COAGULOPATHY 1
280 COLD SWEAT 1
281 COLITIS 1
282 COMA 1
283 COMPLICATION ASSOCIATED WITH DEVICE 1
284 CONDITION AGGRAVATED 1
285 CONJUNCTIVAL HYPERAEMIA 1
286 CRYING 1
287 CYTOKINE STORM 1
288 DECUBITUS ULCER 1
289 DEEP VEIN THROMBOSIS 1
290 DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT 1
291 DELIRIUM 1
292 DERMATITIS 1
293 DERMATITIS ACNEIFORM 1
294 DIPLOPIA 1
295 DISSEMINATED INTRAVASCULAR COAGULATION 1
296 DISTURBANCE IN ATTENTION 1
297 DIVERTICULITIS 1
298 DRUG ERUPTION 1
299 DRY EYE 1
300 DRY MOUTH 1
301 DRY SKIN 1
302 DYSAESTHESIA 1
303 DYSPHONIA 1
304 EARLY SATIETY 1
305 EJECTION FRACTION DECREASED 1
306 EMOTIONAL DISORDER 1
307 EMOTIONAL DISTRESS 1
308 ENCEPHALOPATHY 1
309 ENERGY INCREASED 1
310 ENTERITIS 1
311 EPHELIDES 1
312 EPILEPSY 1
313 EXFOLIATIVE RASH 1
314 EYE EXCISION 1
315 EYE HAEMORRHAGE 1
316 EYE INFECTION 1
317 EYE PRURITUS 1
318 EYE SWELLING 1
319 FACIAL PAIN 1
320 FACIAL PARALYSIS 1
321 FEBRILE NEUTROPENIA 1
322 FEEDING DISORDER 1
323 FEELING COLD 1
324 FEELING HOT 1
325 FIBRIN D DIMER INCREASED 1
326 FOOD ALLERGY 1
327 FULL BLOOD COUNT DECREASED 1
328 FUNCTIONAL GASTROINTESTINAL DISORDER 1
329 GAIT INABILITY 1
330 GASTRITIS EROSIVE 1
331 GASTROINTESTINAL DISORDER 1
332 GASTROINTESTINAL HAEMORRHAGE 1
333 GASTROINTESTINAL NEOPLASM 1
334 GASTROINTESTINAL SOUNDS ABNORMAL 1
335 GASTROINTESTINAL SURGERY 1
336 GASTROINTESTINAL TUBE INSERTION 1
337 GENITOURINARY TRACT NEOPLASM 1
338 GINGIVAL PAIN 1
339 GLOMERULAR FILTRATION RATE DECREASED 1
340 HAEMATOCRIT DECREASED 1
341 HAEMOFILTRATION 1
342 HAEMORRHAGE 1
343 HEAD INJURY 1
344 HEMIPLEGIA 1
345 HEPATIC CIRRHOSIS 1
346 HEPATIC CYTOLYSIS 1
347 HEPATIC ENZYME ABNORMAL 1
348 HEPATOBILIARY NEOPLASM 1
349 HEPATOCELLULAR CARCINOMA 1
350 HEPATORENAL FAILURE 1
351 HEPATORENAL SYNDROME 1
352 HERPES ZOSTER 1
353 HILAR LYMPHADENOPATHY 1
354 HODGKIN^S DISEASE 1
355 HORMONE LEVEL ABNORMAL 1
356 HOSPICE CARE 1
357 HOT FLUSH 1
358 HYPERCREATINAEMIA 1
359 HYPERLEUKOCYTOSIS 1
360 HYPERPYREXIA 1
361 HYPERTENSIVE CRISIS 1
362 HYPERTRANSAMINASAEMIA 1
363 HYPERURICAEMIA 1
364 HYPHAEMA 1
365 HYPOAESTHESIA 1
366 HYPOCALCAEMIA 1
367 HYPOKALAEMIA 1
368 HYPOMAGNESAEMIA 1
369 HYPOTHYROIDISM 1
370 IMMOBILE 1
371 INCOHERENT 1
372 INCONTINENCE 1
373 INCORRECT DOSE ADMINISTERED 1
374 INFLAMMATION 1
375 INFLAMMATORY MARKER INCREASED 1
376 INFLUENZA 1
377 INFUSION SITE EXTRAVASATION 1
378 INJECTION SITE PAIN 1
379 INSOMNIA 1
380 INTERNATIONAL NORMALISED RATIO INCREASED 1
381 INTRACARDIAC MASS 1
382 INVESTIGATION ABNORMAL 1
383 IRIS DISORDER 1
384 ISCHAEMIA 1
385 JOINT SWELLING 1
386 LACRIMATION INCREASED 1
387 LETHARGY 1
388 LEUKAEMIA 1
389 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1
390 LIMB MASS 1
391 LIPASE INCREASED 1
392 LIVEDO RETICULARIS 1
393 LIVER DISORDER 1
394 LYMPHANGIOSIS CARCINOMATOSA 1
395 LYMPHOCYTIC INFILTRATION 1
396 LYMPHOMA 1
397 LYMPHOPENIA 1
398 MAGNETIC RESONANCE IMAGING HEPATOBILIARY ABNORMAL 1
399 MALIGNANT NEOPLASM OLIGOPROGRESSION 1
400 METASTASES TO ADRENALS 1
401 METASTASES TO EYE 1
402 METASTASES TO MENINGES 1
403 METASTASES TO NERVOUS SYSTEM 1
404 METASTASES TO PANCREAS 1
405 METASTASES TO PERITONEUM 1
406 METASTASES TO SPINE 1
407 METASTATIC MALIGNANT MELANOMA 1
408 MICTURITION URGENCY 1
409 MIGRAINE 1
410 MOOD ALTERED 1
411 MOVEMENT DISORDER 1
412 MUCOSAL INFLAMMATION 1
413 MUSCLE ATROPHY 1
414 MUSCLE CONTRACTIONS INVOLUNTARY 1
415 MUSCLE FATIGUE 1
416 MUSCLE SWELLING 1
417 MUSCULOSKELETAL DISCOMFORT 1
418 MUSCULOSKELETAL PAIN 1
419 MUSCULOSKELETAL STIFFNESS 1
420 MYELOID LEUKAEMIA 1
421 MYOCARDIAL INFARCTION 1
422 MYOCARDIAL NECROSIS MARKER INCREASED 1
423 MYOCLONUS 1
424 NEAR DEATH EXPERIENCE 1
425 NEOPLASM 1
426 NEOPLASM SKIN 1
427 NEOPLASM SWELLING 1
428 NEOVASCULARISATION 1
429 NERVOUS SYSTEM DISORDER 1
430 NEUROLOGICAL DECOMPENSATION 1
431 NEUROTOXICITY 1
432 NEUTROPENIA 1
433 NIGHT SWEATS 1
434 NON-HODGKIN^S LYMPHOMA 1
435 NONINFECTIVE GINGIVITIS 1
436 NONSPECIFIC REACTION 1
437 OCULAR HYPERAEMIA 1
438 OESOPHAGEAL FISTULA 1
439 ONYCHOCLASIS 1
440 ORBITAL OEDEMA 1
441 ORTHOSTATIC HYPOTENSION 1
442 ORTHOSTATIC INTOLERANCE 1
443 OSTEOLYSIS 1
444 OSTEOMYELITIS 1
445 PELVIC MASS 1
446 PERFORMANCE STATUS DECREASED 1
447 PERICARDIAL EFFUSION 1
448 PERIORBITAL SWELLING 1
449 PHOTOPHOBIA 1
450 POOR PERIPHERAL CIRCULATION 1
451 PRODUCT ADMINISTRATION INTERRUPTED 1
452 PRODUCT CONTAINER ISSUE 1
453 PRODUCT DISPENSING ISSUE 1
454 PRODUCT SUPPLY ISSUE 1
455 PRODUCT TEMPERATURE EXCURSION ISSUE 1
456 PRODUCT USE IN UNAPPROVED INDICATION 1
457 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1
458 PROTEIN TOTAL DECREASED 1
459 PROTHROMBIN LEVEL INCREASED 1
460 PULMONARY MASS 1
461 RADIATION INJURY 1
462 RADIOTHERAPY 1
463 RASH MACULAR 1
464 RASH MORBILLIFORM 1
465 RECALLED PRODUCT ADMINISTERED 1
466 RECTAL HAEMORRHAGE 1
467 RED BLOOD CELL COUNT DECREASED 1
468 RENAL FUNCTION TEST ABNORMAL 1
469 RENAL IMPAIRMENT 1
470 RENAL INJURY 1
471 RENAL PAIN 1
472 RESPIRATION ABNORMAL 1
473 RESPIRATORY TRACT NEOPLASM 1
474 RESTLESS LEGS SYNDROME 1
475 RETINAL DEPIGMENTATION 1
476 RETINAL OEDEMA 1
477 RETROPERITONEAL MASS 1
478 RHEUMATOID ARTHRITIS 1
479 RHINALGIA 1
480 RHINOVIRUS INFECTION 1
481 SCAN ABNORMAL 1
482 SECOND PRIMARY MALIGNANCY 1
483 SENSATION OF FOREIGN BODY 1
484 SENSITIVE SKIN 1
485 SEPTIC SHOCK 1
486 SHOCK HAEMORRHAGIC 1
487 SKIN BURNING SENSATION 1
488 SKIN DEPIGMENTATION 1
489 SKIN DISORDER 1
490 SKIN LESION 1
491 SKIN OEDEMA 1
492 SKIN PLAQUE 1
493 SKIN REACTION 1
494 SKIN TOXICITY 1
495 SKIN WEEPING 1
496 SOFT TISSUE NEOPLASM 1
497 SPINAL FRACTURE 1
498 SPUTUM DISCOLOURED 1
499 STOMATITIS 1
500 SUDDEN CARDIAC DEATH 1
501 SURGERY 1
502 SUSPECTED OFF LABEL USE 1
503 SWOLLEN TONGUE 1
504 T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA 1
505 THERAPEUTIC EMBOLISATION 1
506 THERAPY NON-RESPONDER 1
507 THUNDERCLAP HEADACHE 1
508 THYROID DISORDER 1
509 TOXIC SKIN ERUPTION 1
510 TROPONIN INCREASED 1
511 TYPE IV HYPERSENSITIVITY REACTION 1
512 ULCER HAEMORRHAGE 1
513 UNDERDOSE 1
514 UNEVALUABLE EVENT 1
515 UNRESPONSIVE TO STIMULI 1
516 URINARY TRACT DISORDER 1
517 URINARY TRACT NEOPLASM 1
518 URINARY TRACT OBSTRUCTION 1
519 URTICARIA 1
520 URTICARIA PAPULAR 1
521 VEIN RUPTURE 1
522 VISION BLURRED 1
523 VISUAL IMPAIRMENT 1
524 VITREOUS HAEMORRHAGE 1
525 VITREOUS OPACITIES 1
526 VULVOVAGINAL BURNING SENSATION 1
527 VULVOVAGINAL PRURITUS 1
528 WEANING FAILURE 1
529 WHEEZING 1
530 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1
531 XEROSIS 1